文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

患有痴呆症和轻度认知障碍的老年人及其护理人员愿意减少药物剂量。

Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed.

机构信息

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.

出版信息

Age Ageing. 2023 Jan 8;52(1). doi: 10.1093/ageing/afac335.


DOI:10.1093/ageing/afac335
PMID:36702513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879708/
Abstract

BACKGROUND: people living with cognitive impairment commonly take multiple medications including potentially inappropriate medications (PIMs), which puts them at risk of medication related harms. AIMS: to explore willingness to have a medication deprescribed of older people living with cognitive impairment (dementia or mild cognitive impairment) and multiple chronic conditions and assess the relationship between willingness, patient characteristics and belief about medications. METHODS: cross-sectional study using results from the revised Patients' Attitudes Towards Deprescribing questionnaire (rPATDcog) collected as baseline data in the OPTIMIZE study, a pragmatic, cluster-randomised trial educating patients and clinicians about deprescribing. Eligible participants were 65+, diagnosed with dementia or mild cognitive impairment, and prescribed at least five-long-term medications. RESULTS: the questionnaire was mailed to 1,409 intervention patients and 553 (39%) were returned and included in analysis. Participants had a mean age of 80.1 (SD 7.4) and 52.4% were female. About 78.5% (431/549) of participants said that they would be willing to have one of their medications stopped if their doctor said it was possible. Willingness to deprescribe was negatively associated with getting stressed when changes are made and with previously having a bad experience with stopping a medication (P < 0.001 for both). CONCLUSION: most older people living with cognitive impairment are willing to deprescribe. Addressing previous bad experiences with stopping a medication and stress when changes are made to medications may be key points to discuss during deprescribing conversations.

摘要

背景:患有认知障碍的人通常会服用多种药物,包括潜在不适当的药物(PIMs),这使他们面临药物相关伤害的风险。

目的:探索患有认知障碍(痴呆或轻度认知障碍)和多种慢性疾病的老年人是否愿意减少用药,并评估其与意愿、患者特征和对药物的信念之间的关系。

方法:这是一项横断面研究,使用 OPTIMIZE 研究中作为基线数据收集的修订版患者对停药态度问卷(rPATDcog)的结果,该研究是一项关于教育患者和临床医生进行停药的实用、集群随机试验。合格的参与者年龄在 65 岁以上,被诊断为痴呆或轻度认知障碍,并开了至少五种长期药物。

结果:问卷邮寄给了 1409 名干预组患者,其中 553 名(39%)返回并纳入分析。参与者的平均年龄为 80.1(7.4)岁,52.4%为女性。约 78.5%(431/549)的参与者表示,如果他们的医生说有可能,他们愿意停止服用一种药物。愿意减少用药与当药物发生变化时感到压力以及之前有过停药不良经历呈负相关(两者均 P<0.001)。

结论:大多数患有认知障碍的老年人愿意减少用药。解决停药不良经历和药物变化时的压力可能是停药对话中需要讨论的关键点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d183/9879708/d63defb71991/afac335f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d183/9879708/d63defb71991/afac335f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d183/9879708/d63defb71991/afac335f1.jpg

相似文献

[1]
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed.

Age Ageing. 2023-1-8

[2]
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.

JAMA Intern Med. 2022-5-1

[3]
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.

Trials. 2020-6-18

[4]
Development and pilot testing of the revised Patients' Attitudes Towards Deprescribing questionnaire for people with cognitive impairment.

Australas J Ageing. 2018-12

[5]
Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study.

Int J Clin Pharm. 2019-4-24

[6]
Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.

Ther Adv Drug Saf. 2021-6-17

[7]
Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Int J Clin Pharm. 2015-10

[8]
Influence of chronic medical conditions on older patients' willingness to deprescribe medications: a cross-sectional study.

BMC Geriatr. 2024-4-4

[9]
Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

J Am Geriatr Soc. 2019-2-13

[10]
A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing.

Int J Environ Res Public Health. 2022-9-11

引用本文的文献

[1]
Top 10 consumer and healthcare professional priorities for research in the field of quality use of medicines in people living with dementia.

J Alzheimers Dis. 2025-7-27

[2]
A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial.

PLoS One. 2025-6-3

[3]
Feasibility and Acceptability of Engaging Care Partners of Persons Living With Dementia With Electronic Outreach for Deprescribing.

Gerontologist. 2025-3-25

[4]
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia.

Drugs Aging. 2024-10

[5]
Influence of chronic medical conditions on older patients' willingness to deprescribe medications: a cross-sectional study.

BMC Geriatr. 2024-4-4

[6]
Medication misuse and overuse in community-dwelling persons with dementia.

J Am Geriatr Soc. 2023-10

本文引用的文献

[1]
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.

JAMA Intern Med. 2022-5-1

[2]
Attitudes toward deprescribing among older adults with dementia in the United States.

J Am Geriatr Soc. 2022-6

[3]
Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis.

J Gerontol A Biol Sci Med Sci. 2022-5-5

[4]
The value of deprescribing in older adults with dementia: a narrative review.

Expert Rev Clin Pharmacol. 2021-11

[5]
Barriers and enablers of older adults initiating a deprescribing conversation.

Patient Educ Couns. 2022-3

[6]
Exploring stakeholder roles in medication management for people living with dementia.

Res Social Adm Pharm. 2021-4

[7]
Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents.

J Am Geriatr Soc. 2021-6

[8]
Alterations in drug disposition in older adults: a focus on geriatric syndromes.

Expert Opin Drug Metab Toxicol. 2021-1

[9]
Impact of the Goal-directed Medication Review Electronic Decision Support System on Drug Burden Index: A cluster-randomised clinical trial in primary care.

Br J Clin Pharmacol. 2021-3

[10]
The utility of a computerised clinical decision support system intervention in home medicines review: A mixed-methods process evaluation.

Res Social Adm Pharm. 2021-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索